Article
[Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Zhonghua zhong liu za zhi [Chinese journal of oncology] - 23 Mar 2018
Luo H X, Du H, Liu Z H, Zhang L J, Wang C, Wu R F
Abstract excerpt
Objective: To determine the morbidity of cervical intraepithelial neoplasia 2+ (CIN2+ ) and CIN3+ of different human papillomavirus(HPV) subtype infection combined with different cytology status. Methods: The Shenzhen Cervical Cancer Screening Trial Ⅰ & Ⅱ (SHENCCASTⅠ&Ⅱ) are population-based cross-sectional cervical cancer screening studis conducted in Shenzhen and surrounding area from 2008 to 2010. A total of 12...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
